As such, we are involved in the Marseille immunology biotope
I am the Director of Protisvalor, the research transfer subsidiary of Aix-Marseille University. Protisvalor was founded in 2002 to provide laboratories and researchers with the necessary assistance to valorize their expertise and the results of their research. Since then, we have actively supported the University’s teams in their innovation activities and collaborations with industry and ensure the administrative and financial management of strategic R&D platforms, such as the MI-mAbs pre-industrial demonstrator.
As such, we are involved in the Marseille immunology biotope, so it is natural that today we fully support this initiative.#ecosystem
Each year, a large number of clinical trials are conducted by APHM clinicians alone or in partnership with industry players in biopharmaceuticals.
AMU, AP-HM, CIML
HalioDx is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.
New molecules currently under development at Innate Pharma and in new companies in Marseille reflect the teams' dynamism and local potential.
Marseille Immunopole should allow us now to accelerate the development of therapeutic antibodies, the new drugs that are changing the course of cancer treatment.
AMU, IPC, CRCM